Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia. Eyre T et al Blood 2012 120(22):4441-4443

Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL. Morak M et al Blood 2012 120 (26): 5134-5142

Distinct patterns of gained chromosomes in high hyperdiploid acute lymphoblastic leukemia with t(1;19)(q23;p13), t(9;22)(q34;q22) or MLL rearrangements. Paulsson K et al Leukemia 2012 26(10):139-140

Genomic analysis drives tailored therapy in poor risk childhood leukemia. Harrison CJ Cancer Cell 2012 22(2):139-140

BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia. Buitenkamp TD et al Leukemia 2012 26(8):1-2

IGH@ Translocations, CRLF2 Deregulation, and Microdeletions in Adolescents and Adults With Acute Lymphoblastic Leukemia. Moorman AV et al J Clin Oncol 2012 30(25):3100-3108

The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia. Moorman AV Blood Rev 2012 26(3):123-135

Treatment outcome of CRLF2 -rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups. Attarbaschi A et al Br J Haematol 2012 158(6):772-777

Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial. Jenkinson S et al Leukemia 2012 26:1-7

Outcome in children with Down syndrome and Acute Lymphoblastic Leukemia: role of IKZF1 deletions and CRLF2 aberrations. Buitenkamp TD et al Leukemia 2012 26(3):2204-2211

The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia. Moorman AV Blood Rev 2012 26(3):123-135

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial. Sive JI et al Br J Haematol 2012 157(4):463-471

Burkitt's lymphoma. Molyneux EM et al Lancet 2012 379(9822):1234-1244

Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity. Thathia SH et al Haematologica 2012 97(3):371-378